KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Assets Average: 2011-2024

Historic Assets Average for Pacira BioSciences (PCRX) over the last 14 years, with Dec 2024 value amounting to $1.6 billion.

  • Pacira BioSciences' Assets Average fell 10.53% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 10.53%. This contributed to the annual value of $1.6 billion for FY2024, which is 3.92% down from last year.
  • Latest data reveals that Pacira BioSciences reported Assets Average of $1.6 billion as of FY2024, which was down 3.92% from $1.6 billion recorded in FY2023.
  • Pacira BioSciences' Assets Average's 5-year high stood at $1.9 billion during FY2022, with a 5-year trough of $1.1 billion in FY2020.
  • Moreover, its 3-year median value for Assets Average was $1.6 billion (2023), whereas its average is $1.7 billion.
  • As far as peak fluctuations go, Pacira BioSciences' Assets Average surged by 59.09% in 2021, and later dropped by 13.34% in 2023.
  • Pacira BioSciences' Assets Average (Yearly) stood at $1.1 billion in 2020, then spiked by 59.09% to $1.7 billion in 2021, then grew by 12.14% to $1.9 billion in 2022, then declined by 13.34% to $1.6 billion in 2023, then decreased by 3.92% to $1.6 billion in 2024.